Latest filing published 27 Sept 2013 for PREMIER BIOMEDICAL INC, €37k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Richard Thomas Najarian: trading record in brief
Richard Thomas Najarian discloses dealings in Premier Biomedical Inc to SEC (Form 4). In total, 3 filings cover trades dated from 20 February 2013 to 25 September 2013.
Every open-market trade on record is a purchase: 1 purchase worth €56k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants.
Most recently, on 27 September 2013, the filings show a share grant worth €37k in Premier Biomedical Inc. The latest purchase dates back some time: it was published 5,008 days ago, on 22 February 2013. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Richard Thomas Najarian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares@ US$0.05Common StockSEC:0001135432-13-000016:0
- 1,500,000 shares@ US$0.05Common StockSEC:0001556722-13-000001:0Canonical exit: 21 May 2013 (T+90)
2 of 2 declarations